Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRILACICLIB vs TRIMIPRAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRILACICLIB vs TRIMIPRAMINE: Safety Overview

Metric TRILACICLIB TRIMIPRAMINE
Total FAERS Reports 226 683
Deaths Reported 29 114
Death Rate 12.8% 16.7%
Hospitalizations 96 354
Average Patient Age 62.2 yrs 54.5 yrs
% Female Patients 43.9% 67.6%
FDA Approval Date Feb 12, 2021 Approved Prior to Jan 1, 1982
Manufacturer Pharmacosmos Therapeutics Inc. Bryant Ranch Prepack
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued